Badawi, M., Kim, J., Dauki, A., Sutaria, D., Motiwala, T., Reyes, R., . . . Schmittgen, T. D. (2018). CD44 positive and sorafenib insensitive hepatocellular carcinomas respond to the ATP-competitive mTOR inhibitor INK128. Oncotarget.
Citação norma ChicagoBadawi, Mohamed, et al. "CD44 Positive and Sorafenib Insensitive Hepatocellular Carcinomas Respond to the ATP-competitive MTOR Inhibitor INK128." Oncotarget 2018.
Citação norma MLABadawi, Mohamed, et al. "CD44 Positive and Sorafenib Insensitive Hepatocellular Carcinomas Respond to the ATP-competitive MTOR Inhibitor INK128." Oncotarget 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.